UNIT-6- Drugs used in treatment of endocrine system disorders
Drugs Used in the Treatment of Endocrine System Disorders: Introduction
1. Introduction
The endocrine system consists of glands that produce hormones to regulate metabolism, growth, development, and homeostasis. Disorders occur due to hormonal excess, deficiency, or dysfunction, requiring pharmacological intervention to restore balance.
Drugs used for endocrine disorders either:
Replace deficient hormones (e.g., insulin for diabetes, levothyroxine for hypothyroidism).
Suppress excessive hormone production (e.g., methimazole for hyperthyroidism, corticosteroids for adrenal hyperactivity).
3. General Classification of Drugs for Endocrine Disorders
Category
Examples
Indications
1. Hormone Replacement Therapy
Insulin, Levothyroxine, Hydrocortisone
Diabetes, Hypothyroidism, Addison’s Disease
2. Antithyroid Drugs
Methimazole, Propylthiouracil (PTU)
Hyperthyroidism
3. Oral Hypoglycemics
Metformin, Sulfonylureas
Type 2 Diabetes
4. Glucocorticoids
Prednisone, Dexamethasone
Inflammation, Addison’s Disease
5. Mineralocorticoids
Fludrocortisone
Addison’s Disease
6. Parathyroid Modulators
Calcitriol, Cinacalcet
Hypoparathyroidism, Hyperparathyroidism
7. Growth Hormone Therapy
Somatropin, Octreotide
Growth Disorders (Dwarfism, Acromegaly)
8. Sex Hormones & Antagonists
Estrogen, Testosterone, Tamoxifen
Menopause, Hypogonadism, PCOS, Breast Cancer
4. Importance of These Drugs
Restore normal hormone levels to prevent complications.
Improve metabolism, growth, and reproduction.
Prevent long-term complications like heart disease, osteoporosis, and nerve damage in diabetes.
Insulin & Oral Hypoglycemics:
1. Introduction
Insulin and oral hypoglycemic agents are used to control blood glucose levels in patients with diabetes mellitus. They help prevent complications such as diabetic ketoacidosis (DKA), neuropathy, retinopathy, nephropathy, and cardiovascular diseases.
2. Insulin
A. Composition of Insulin
Insulin is a polypeptide hormone produced by the beta cells of the pancreas. The main types of insulin used in therapy include:
Human Insulin (Recombinant DNA technology)
Analog Insulin (Modified human insulin for better absorption and effect)
B. Types of Insulin & Their Action
Type
Examples
Onset
Peak
Duration
Rapid-Acting
Lispro, Aspart, Glulisine
10-30 min
1-2 hrs
3-5 hrs
Short-Acting
Regular Insulin (Humulin R, Actrapid)
30-60 min
2-4 hrs
5-8 hrs
Intermediate-Acting
NPH (Humulin N, Insulatard)
1-2 hrs
6-12 hrs
12-18 hrs
Long-Acting
Glargine, Detemir, Degludec
1-2 hrs
No peak
24-42 hrs
Premixed
70/30 (NPH/Regular), 50/50, 75/25
Varies
Dual peak
10-24 hrs
C. Dosage & Route
Dosage: Individualized based on blood glucose levels, insulin sensitivity, and lifestyle.
Route: Subcutaneous (SC) (most common), Intravenous (IV) (only regular insulin in emergencies like DKA).
Dosage: Individualized based on HbA1c levels and patient response.
Route: Oral (tablets or extended-release formulations).
C. Indications
Type 2 Diabetes Mellitus
Prediabetes (Metformin)
Polycystic Ovarian Syndrome (PCOS) (Metformin)
D. Contraindications
Drug Class
Contraindications
Metformin
Renal failure (GFR <30), lactic acidosis risk
Sulfonylureas
Severe liver/kidney disease
TZDs
Heart failure, bladder cancer
SGLT-2 Inhibitors
Severe kidney disease
E. Drug Interactions
Oral Hypoglycemic
Interacting Drug
Effect
Metformin
Contrast agents (iodine)
Lactic acidosis risk
Sulfonylureas
NSAIDs, Alcohol
Increased hypoglycemia risk
TZDs
Insulin
Increased heart failure risk
SGLT-2 Inhibitors
Diuretics
Dehydration, hypotension
F. Side Effects
Drug Class
Common Side Effects
Metformin
Nausea, diarrhea, lactic acidosis (rare)
Sulfonylureas
Hypoglycemia, weight gain
TZDs
Fluid retention, weight gain
DPP-4 Inhibitors
Nasopharyngitis, pancreatitis
SGLT-2 Inhibitors
UTI, dehydration, ketoacidosis
Alpha-Glucosidase Inhibitors
Flatulence, diarrhea
G. Adverse Effects & Toxicity
Metformin Toxicity: Lactic acidosis (treated with sodium bicarbonate & dialysis).
Sulfonylurea Overdose: Severe hypoglycemia (treated with IV dextrose).
TZDs: Risk of heart failure & bone fractures.
H. Role of the Nurse in Oral Hypoglycemics
✅ Before Administration
Check renal & liver function (Metformin, TZDs).
Assess for hypoglycemia risk.
✅ During Administration
Give with food (Sulfonylureas) to prevent hypoglycemia.
Monitor for GI symptoms (Metformin).
✅ After Administration
Teach lifestyle modifications (exercise, diet).
Advise on self-monitoring of glucose levels.
Educate on hypoglycemia symptoms & management.
Thyroid and Anti-Thyroid Drugs:
1. Introduction
Thyroid hormones regulate metabolism, growth, energy production, and organ function. Thyroid disorders occur due to excessive (hyperthyroidism) or insufficient (hypothyroidism) hormone levels. Medications are used to replace deficient hormones or suppress overactive thyroid function.
2. Thyroid Hormones (For Hypothyroidism)
A. Composition of Thyroid Hormones
Drug
Composition
Levothyroxine (T4)
Synthetic Thyroxine (T4)
Liothyronine (T3)
Synthetic Triiodothyronine (T3)
Desiccated Thyroid (Armour Thyroid)
Animal-derived T3 & T4 mix
B. Mechanism of Action
Levothyroxine (T4): Converts to T3 (active form) in the body, replacing deficient thyroid hormone.
Liothyronine (T3): Directly provides active thyroid hormone for rapid action.
C. Dosage & Route
Drug
Dosage
Route
Levothyroxine
25-200 mcg/day
Oral, IV (for myxedema coma)
Liothyronine
5-25 mcg/day
Oral, IV
Desiccated Thyroid
15-120 mg/day
Oral
D. Indications
Hypothyroidism (Primary & Secondary)
Congenital Hypothyroidism (Cretinism)
Myxedema Coma (Severe hypothyroidism)
Goiter (due to iodine deficiency)
Post-Thyroidectomy Hormone Replacement
E. Contraindications
Untreated adrenal insufficiency
Thyrotoxicosis
Recent myocardial infarction
Hyperthyroidism (unless adjusting dose for treatment)
F. Drug Interactions
Interacting Drug
Effect
Iron, Calcium, Antacids
Reduce absorption
Warfarin
Increases anticoagulant effect
Beta-Blockers
Reduces effectiveness
Oral Hypoglycemics
May require dose adjustment
G. Side Effects
Insomnia, weight loss, tremors
Palpitations, tachycardia
Heat intolerance, sweating
Nervousness, anxiety
H. Adverse Effects & Toxicity
Hyperthyroidism-like symptoms (thyrotoxicosis)
Atrial fibrillation, osteoporosis (long-term use)
Acute overdose: Thyroid storm (requires beta-blockers, IV fluids)
I. Role of the Nurse in Thyroid Hormone Therapy
✅ Before Administration
Check TSH, T3, T4 levels.
Assess heart rate and BP.
Give on an empty stomach (morning, 30 min before food).
✅ During Administration
Monitor for overdose symptoms (palpitations, weight loss).
Adjust dose gradually.
✅ After Administration
Educate on lifelong therapy.
Avoid abrupt discontinuation.
Monitor for signs of effectiveness (improved energy, stable weight, normal HR).
Calcitonin, Parathormone, Vitamin D3, and Calcium Metabolism.
1. Introduction
The calcium metabolism system regulates blood calcium levels through the interaction of hormones (calcitonin & parathormone), vitamin D3, and calcium salts. These components are essential for bone health, nerve conduction, muscle contraction, and blood clotting.
Calcitonin lowers calcium levels by inhibiting bone resorption.
Parathyroid Hormone (PTH) increases calcium levels by stimulating bone resorption, enhancing intestinal absorption, and reducing renal excretion.
Vitamin D3 (Cholecalciferol) promotes calcium absorption in the intestines.
Calcium salts are used for calcium supplementation.
2. Calcitonin
A. Composition of Calcitonin
Drug
Composition
Calcitonin-Salmon
Synthetic salmon calcitonin
Human Calcitonin
Recombinant human calcitonin
B. Mechanism of Action
Inhibits osteoclast activity, reducing bone resorption.
Increases calcium excretion by kidneys, lowering serum calcium levels.
C. Dosage & Route
Drug
Dosage
Route
Calcitonin-Salmon
50-100 IU/day
SC, IM, Nasal Spray
Human Calcitonin
0.5-1 mg/day
SC, IV
D. Indications
Hypercalcemia
Osteoporosis
Paget’s Disease
Bone pain from metastatic cancer
E. Contraindications
Hypocalcemia
Allergy to calcitonin
Pregnancy & breastfeeding
F. Drug Interactions
Interacting Drug
Effect
Bisphosphonates
Enhanced effect in osteoporosis
Loop Diuretics
Increased calcium loss
Lithium
Decreased lithium effectiveness
G. Side Effects
Nausea, vomiting
Flushing of the face
Hypocalcemia (muscle cramps, tingling)
Nasal irritation (with nasal spray)
H. Adverse Effects & Toxicity
Severe hypocalcemia (tetany, muscle spasms)
Allergic reactions (anaphylaxis)
Long-term nasal spray use → Nasal ulceration
🔹 Management of Toxicity:
Calcium & Vitamin D supplementation.
Discontinue drug if severe allergic reaction occurs.
I. Role of the Nurse in Calcitonin Therapy
✅ Before Administration
Check serum calcium levels.
Assess for nasal irritation (if using nasal spray).
✅ During Administration
Rotate injection sites (SC, IM).
Monitor for hypocalcemia symptoms.
✅ After Administration
Educate patients on nasal spray use (alternate nostrils).
Encourage calcium-rich diet.
3. Parathyroid Hormone (Parathormone – PTH)
A. Composition of Parathyroid Hormone
Drug
Composition
Teriparatide
Recombinant human PTH (1-34)
Natpara
Full-length recombinant PTH
B. Mechanism of Action
Stimulates osteoblasts, increasing bone formation.
Enhances calcium reabsorption in kidneys.
Increases intestinal calcium absorption via Vitamin D activation.
C. Dosage & Route
Drug
Dosage
Route
Teriparatide
20 mcg/day
SC
Natpara
50-100 mcg/day
SC
D. Indications
Osteoporosis (high fracture risk)
Hypoparathyroidism
Severe vitamin D-resistant rickets
E. Contraindications
Hypercalcemia
Paget’s disease
Bone cancer history
F. Drug Interactions
Interacting Drug
Effect
Digoxin
Increased risk of toxicity
Loop Diuretics
Increased calcium loss
G. Side Effects
Dizziness, nausea
Hypercalcemia (kidney stones, constipation)
Leg cramps
H. Adverse Effects & Toxicity
Osteosarcoma risk (long-term use)
Severe hypercalcemia (confusion, arrhythmias)
🔹 Management of Toxicity:
Reduce calcium intake.
Monitor renal function.
I. Role of the Nurse in Parathormone Therapy
✅ Before Administration
Assess calcium levels.
Check renal function.
✅ During Administration
Administer SC in the thigh.
Monitor for dizziness (fall risk).
✅ After Administration
Educate on daily SC injections.
Ensure adequate calcium intake.
4. Vitamin D3 (Cholecalciferol)
A. Composition of Vitamin D3
Drug
Composition
Cholecalciferol
Vitamin D3
Ergocalciferol
Vitamin D2
Calcitriol
Active Vitamin D3
B. Mechanism of Action
Enhances calcium & phosphorus absorption in intestines.
Educate on sunlight exposure for natural Vitamin D.
Monitor calcium intake.
5. Calcium Salts
A. Types of Calcium Salts
Calcium Supplement
Elemental Calcium Content
Calcium Carbonate
40%
Calcium Citrate
21%
Calcium Gluconate
9%
B. Indications
Osteoporosis prevention
Hypocalcemia
Hyperkalemia (Calcium Gluconate IV)
C. Adverse Effects
Constipation
Hypercalcemia (kidney stones, confusion)
🔹 Management:
Hydration & dietary balance.
Role and Responsibilities of Nurses in the Administration of Drugs for Endocrine System Disorders
1. Introduction
The endocrine system regulates metabolism, growth, development, and homeostasis through hormones. Disorders such as diabetes, hypothyroidism, hyperthyroidism, adrenal dysfunction, osteoporosis, and calcium imbalances require pharmacological intervention. Nurses play a crucial role in safe drug administration, patient education, monitoring therapy, and preventing complications.
2. Drugs Used for Endocrine Disorders & Nursing Responsibilities
Endocrine Disorder
Drug Class
Examples
Diabetes Mellitus
Insulin, Oral Hypoglycemics
Insulin, Metformin, Glipizide, Dapagliflozin
Hypothyroidism
Thyroid Hormones
Levothyroxine, Liothyronine
Hyperthyroidism
Anti-Thyroid Drugs
Methimazole, Propylthiouracil
Adrenal Insufficiency (Addison’s Disease)
Glucocorticoids & Mineralocorticoids
Prednisone, Hydrocortisone, Fludrocortisone
Cushing’s Syndrome
Cortisol Inhibitors
Ketoconazole, Metyrapone
Osteoporosis
Bisphosphonates, Calcitonin
Alendronate, Risedronate, Calcitonin
Calcium Disorders
Calcium & Vitamin D, PTH Analogues
Calcium Gluconate, Calcitriol, Teriparatide
3. Nursing Responsibilities in Endocrine Drug Administration
Nurses have multiple roles in ensuring safe and effective medication therapy for endocrine disorders.